To investigate the predictive relevance among patients with different breast cancer subtypes, we performed further Kaplan-Meier analysis to compare RFS probability based on OTUD7B expression for patients represented in Figure 5A with luminal A/B, HER2-positive and basal-like breast cancers (Figure 5C–5F). Here, ERBB2 is linked to breast cancer.